PCR.WA
PCC Rokita SA
Price:  
61.80 
PLN
Volume:  
5,720.00
Poland | Chemicals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PCR.WA WACC - Weighted Average Cost of Capital

The WACC of PCC Rokita SA (PCR.WA) is 10.4%.

The Cost of Equity of PCC Rokita SA (PCR.WA) is 12.55%.
The Cost of Debt of PCC Rokita SA (PCR.WA) is 6.00%.

Range Selected
Cost of equity 10.70% - 14.40% 12.55%
Tax rate 10.70% - 12.30% 11.50%
Cost of debt 5.30% - 6.70% 6.00%
WACC 8.9% - 11.8% 10.4%
WACC

PCR.WA WACC calculation

Category Low High
Long-term bond rate 5.5% 6.0%
Equity market risk premium 6.3% 7.3%
Adjusted beta 0.82 1.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.70% 14.40%
Tax rate 10.70% 12.30%
Debt/Equity ratio 0.43 0.43
Cost of debt 5.30% 6.70%
After-tax WACC 8.9% 11.8%
Selected WACC 10.4%

PCR.WA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PCR.WA:

cost_of_equity (12.55%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.82) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.